Michael S. Torbenson
Torbenson, Michael S.
Torbenson, Michael S., 19..-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 307435462 (Personal)
Permalink: http://viaf.org/viaf/307435462
Preferred Forms
-
100 0 _
‡a
Michael S. Torbenson
-
200 _ |
‡a
Torbenson
‡b
Michael S.
-
100 1 _ ‡a Torbenson, Michael S.
-
100 1 _ ‡a Torbenson, Michael S.
-
100 1 _ ‡a Torbenson, Michael S.
-
100 1 _
‡a
Torbenson, Michael S.
-
100 1 _ ‡a Torbenson, Michael S.
-
100 1 _
‡a
Torbenson, Michael S.
-
100 1 _
‡a
Torbenson, Michael S.
-
100 1 _ ‡a Torbenson, Michael S.
-
100 1 _ ‡a Torbenson, Michael S.
-
100 1 _
‡a
Torbenson, Michael S.,
‡d
19..-....
4xx's: Alternate Name Forms (4)
Works
| Title | Sources |
|---|---|
| Atlas of liver pathology a pattern-based approach |
|
| Biopsy interpretation of the liver |
|
| Loss of SDHB and NF1 genes in a malignant phyllodes tumor of the breast as detected by oligo-array comparative genomic hybridization |
|
| Low frequency of Helicobacter DNA in benign and malignant liver tissues from Baltimore, United States |
|
| Malignant transformation of hepatic adenomas. |
|
| Man With Fever and Severe Diarrhea |
|
| Marked iron in liver explants in the absence of major hereditary hemochromatosis gene defects: a risk factor for cardiac failure |
|
| Methylation regulates hepatitis B viral protein expression |
|
| MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer |
|
| MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. |
|
| MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. |
|
| Misuse of scoring systems |
|
| Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas |
|
| MRI arterial enhancement fraction in hepatic fibrosis and cirrhosis. |
|
| mTOR and P70 S6 kinase expression in primary liver neoplasms |
|
| Myxoid hepatocellular neoplasms: imaging appearance of a unique mucinous tumor variant |
|
| Neonatal giant cell hepatitis: histological and etiological findings |
|
| New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer |
|
| Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study |
|
| Non-neoplastic diseases of the liver |
|
| Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice |
|
| Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. |
|
| Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity |
|
| Occult hepatitis B. |
|
| Occurrence of a multimeric high-molecular-weight glyceraldehyde-3-phosphate dehydrogenase in human serum |
|
| Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity |
|
| PEG-b-PPA/DNA micelles improve transgene expression in rat liver through intrabiliary infusion. |
|
| Perihilar Cholangiocarcinoma |
|
| Phenotypic and Genotypic Differences Between a Child With Vertically Acquired Severe Hepatitis C Liver Disease and His Mother |
|
| Pigmented hepatocellular adenomas have a high risk of atypia and malignancy |
|
| Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome |
|
| Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes |
|
| Primary hepatic tumors with myxoid change: morphologically unique hepatic adenomas and hepatocellular carcinomas |
|
| Primary liver carcinoma arising in people younger than 30 years |
|
| Progression of liver fibrosis among injection drug users with chronic hepatitis C. |
|
| Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma |
|
| Punctured Human Bones of the Laurel Culture from Smith Mound Four, Minnesota |
|
| Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients |
|
| Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults |
|
| Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct |
|
| Relation between vitamin D status and nonalcoholic fatty liver disease in children |
|
| Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV |
|
| Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma. |
|
| Review of the clinicopathologic features of fibrolamellar carcinoma |
|
| The Rodger C. Haggitt Gastrointestinal Pathology Society at the 2020 United States and Canadian Academy of Pathology: A Mini-symposium |
|
| Role for hedgehog signaling in hepatic stellate cell activation and viability |
|
| Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma |
|
| The Role of Magnetic Resonance Elastography in the Diagnosis of Noncirrhotic Portal Hypertension |
|
| Segmental atrophy of the liver: a distinctive pseudotumor of the liver with variable histologic appearances |
|
| Selenium supplementation decreases hepatic fibrosis in mice after chronic carbon tetrachloride administration |
|
| Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury. |
|
| Severity and correlates of liver disease in hepatitis C virus-infected injection drug users |
|
| Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma |
|
| Simultaneous Evaluation of Safety, Acceptability, Pericoital Kinetics, and Ex Vivo Pharmacodynamics Comparing Four Rectal Microbicide Vehicle Candidates |
|
| Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. |
|
| Sirolimus monotherapy versus sirolimus in combination with steroids and/or MMF for immunosuppression after liver transplantation |
|
| Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis |
|
| STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers |
|
| Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study |
|
| String-like micellar nanoparticles formed by complexation of PEG-b-PPA and plasmid DNA and their transfection efficiency. |
|
| Successful treatment of severe refractory hepatic graft-versus-host disease by cadaveric liver transplant |
|
| Surgical pathology of the liver |
|
| Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation |
|
| Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury |
|
| Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice |
|
| Targeted transarterial therapy of Vx-2 rabbit liver tumor with Yttrium-90 labeled ferromagnetic particles using an external magnetic field |
|
| TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL. |
|
| Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model |
|
| Transgenic hepatitis B: a new model of HBV infection |
|
| Treatment of chronic hepatitis C: a systematic review |
|
| Treponema pallidum Immunohistochemistry is positive in human intestinal Spirochetosis. |
|
| Tuberculosis-associated haemophagocytic syndrome. |
|
| Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B. |
|
| Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response |
|
| Unmet needs and new models for future trials in autoimmune hepatitis. |
|
| Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver |
|
| Use of T-cell antibodies for donor dosaging in a canine model of in utero hematopoietic stem cell transplantation. |
|
| Uterine tumor resembling ovarian sex cord tumor: report of a case with t(X;6)(p22.3;q23.1) and t(4;18)(q21.1;q21.3). |
|
| The Utility of MR Elastography to Differentiate Nodular Regenerative Hyperplasia from Cirrhosis |
|
| Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3 |
|
| Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection |
|
| Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic category |
|
